Thermo Fisher Scientific (TMO) Tops Q4 EPS by 1c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2019 Results
January 30, 2020 6:00 AM ESTWALTHAM, Mass., Jan. 30, 2020 /PRNewswire/ --Â Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2019.
Fourth Quarter and Full Year 2019 Highlights
Fourth quarter revenue increased 5% to $6.83 billion. Fourth quarter GAAP diluted earnings per share (EPS) increased 12% to $2.49. Fourth quarter adjusted EPS increased 9% to $3.55.                                     Full year revenue grew 5% to $25.54 billion. Full year GAAP diluted EPS increased 27% to $9.17. Full year adjusted EPS increased 11% to $12.35.                             Delivered another excellent year of high-impact innovation, launching new products... More